247 related articles for article (PubMed ID: 25604494)
21. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals.
Gongvatana A; Schweinsburg BC; Taylor MJ; Theilmann RJ; Letendre SL; Alhassoon OM; Jacobus J; Woods SP; Jernigan TL; Ellis RJ; Frank LR; Grant I;
J Neurovirol; 2009 Apr; 15(2):187-95. PubMed ID: 19306228
[TBL] [Abstract][Full Text] [Related]
22. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group.
Stout JC; Ellis RJ; Jernigan TL; Archibald SL; Abramson I; Wolfson T; McCutchan JA; Wallace MR; Atkinson JH; Grant I
Arch Neurol; 1998 Feb; 55(2):161-8. PubMed ID: 9482357
[TBL] [Abstract][Full Text] [Related]
23. Brain Volumetric Alterations in Preclinical HIV-Associated Neurocognitive Disorder Using Automatic Brain Quantification and Segmentation Tool.
Li R; Qi Y; Shi L; Wang W; Zhang A; Luo Y; Kung WK; Jiao Z; Liu G; Li H; Zhang L
Front Neurosci; 2021; 15():713760. PubMed ID: 34456678
[TBL] [Abstract][Full Text] [Related]
24. Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging.
Chang L; Andres M; Sadino J; Jiang CS; Nakama H; Miller E; Ernst T
Neuroimage; 2011 Oct; 58(4):1017-27. PubMed ID: 21803164
[TBL] [Abstract][Full Text] [Related]
25. Structural Neuroimaging and Neuropsychologic Signatures in Children With Vertically Acquired HIV.
Paul R; Prasitsuebsai W; Jahanshad N; Puthanakit T; Thompson P; Aurpibul L; Hansudewechakul R; Kosalaraksa P; Kanjanavanit S; Ngampiyaskul C; Luesomboon W; Lerdlum S; Pothisri M; Visrutaratna P; Valcour V; Nir TM; Saremi A; Kerr S; Ananworanich J;
Pediatr Infect Dis J; 2018 Jul; 37(7):662-668. PubMed ID: 29200184
[TBL] [Abstract][Full Text] [Related]
26. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia.
Aylward EH; Brettschneider PD; McArthur JC; Harris GJ; Schlaepfer TE; Henderer JD; Barta PE; Tien AY; Pearlson GD
Am J Psychiatry; 1995 Jul; 152(7):987-94. PubMed ID: 7793469
[TBL] [Abstract][Full Text] [Related]
28. Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
Price CC; Tanner JJ; Schmalfuss IM; Brumback B; Heilman KM; Libon DJ
J Alzheimers Dis; 2015; 48(3):833-47. PubMed ID: 26402109
[TBL] [Abstract][Full Text] [Related]
29. Reductions in Gray Matter Linked to Epigenetic HIV-Associated Accelerated Aging.
Lew BJ; Schantell MD; O'Neill J; Morsey B; Wang T; Ideker T; Swindells S; Fox HS; Wilson TW
Cereb Cortex; 2021 Jul; 31(8):3752-3763. PubMed ID: 33822880
[TBL] [Abstract][Full Text] [Related]
30. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.
Sanford R; Fernandez Cruz AL; Scott SC; Mayo NE; Fellows LK; Ances BM; Collins DL
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):563-570. PubMed ID: 28129254
[TBL] [Abstract][Full Text] [Related]
31. Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.
Guha A; Brier MR; Ortega M; Westerhaus E; Nelson B; Ances BM
J Acquir Immune Defic Syndr; 2016 Dec; 73(4):374-383. PubMed ID: 27454251
[TBL] [Abstract][Full Text] [Related]
32. Different roles of frontal versus striatal atrophy in HIV-associated neurocognitive disorders.
Israel SM; Hassanzadeh-Behbahani S; Turkeltaub PE; Moore DJ; Ellis RJ; Jiang X
Hum Brain Mapp; 2019 Jul; 40(10):3010-3026. PubMed ID: 30921494
[TBL] [Abstract][Full Text] [Related]
33. HIV clades B and C are associated with reduced brain volumetrics.
Ortega M; Heaps JM; Joska J; Vaida F; Seedat S; Stein DJ; Paul R; Ances BM
J Neurovirol; 2013 Oct; 19(5):479-87. PubMed ID: 24078556
[TBL] [Abstract][Full Text] [Related]
34. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
[TBL] [Abstract][Full Text] [Related]
35. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
36. Frailty Characteristics in Chronic HIV Patients are Markers of White Matter Atrophy Independently of Age and Depressive Symptoms: A Pilot Study.
Kallianpur KJ; Sakoda M; Gangcuangco LM; Ndhlovu LC; Umaki T; Chow D; Wongjittraporn S; Shikuma CM
Open Med J; 2016; 3():138-152. PubMed ID: 27721908
[TBL] [Abstract][Full Text] [Related]
37. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier.
Power C; Kong PA; Crawford TO; Wesselingh S; Glass JD; McArthur JC; Trapp BD
Ann Neurol; 1993 Sep; 34(3):339-50. PubMed ID: 7689819
[TBL] [Abstract][Full Text] [Related]
38. Stereological analysis of cerebral atrophy in human immunodeficiency virus-associated dementia.
Subbiah P; Mouton P; Fedor H; McArthur JC; Glass JD
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1032-7. PubMed ID: 8858000
[TBL] [Abstract][Full Text] [Related]
39. A short tool to screen HIV-infected patients for mild neurocognitive disorders - a pilot study.
Fasel D; Kunze U; Elzi L; Werder V; Niepmann S; Monsch AU; Schumacher R; Battegay M
BMC Psychol; 2014; 2(1):21. PubMed ID: 25815192
[TBL] [Abstract][Full Text] [Related]
40. Early prediction of putamen imaging features in HIV-associated neurocognitive impairment syndrome.
Qi Y; Xu M; Wang W; Wang YY; Liu JJ; Ren HX; Liu MM; Li RL; Li HJ
BMC Neurol; 2021 Mar; 21(1):106. PubMed ID: 33750319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
